Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro

Journal of Cerebral Blood Flow and Metabolism

Volumn 22, Issue 5, 2002, Pages 520-525

  Prass, Konstantin ^a   Ruscher, Karsten ^a   Karsch, Maria ^a   Isaev, Nikolay ^a   Megow, Dirk ^a   Priller, Josef ^a   Scharff, Anna ^a   Dirnagl, Ulrich ^a   Meisel, Andreas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Erythropoietin; Hypoxia inducible factor 1; Mouse; Neuronal culture; Rat; Stroke

Indexed keywords

DEFEROXAMINE; DNA; ERYTHROPOIETIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA BINDING; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION; TREATMENT OUTCOME;

EID: 0036249884     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200205000-00003     Document Type: Article

References (43)

1. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain
2. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
3. Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brain
4. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus
5. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
6. Focal brain ischemia in the rat: Methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries
7. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major
8. Induction of tolerance in rat cortical neurons: Hypoxic preconditioning
9. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation
10. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades
11. Localization of specific erythropoietin binding sites in defined areas of the mouse brain
12. Pathobiology of ischemic stroke: An integrated view
13. Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and post-mitotic sympathetic neurons after removal of trophic support
14. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops
15. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning
16. TNF-alpha pretreatment prevents subsequent activation of cultured brain cells with TNF-alpha and hypoxia via ceramide
17. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning
18. Ischemic tolerance in murine cortical cell culture: Critical role for NMDA receptors
19. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion
20. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain
21. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death
22. Cortical spreading depression induces long-term alterations of BDNF levels in cortex and hippocampus distinct from lesion effects: Implications for ischemic tolerance
23. "Ischemic tolerance" phenomenon found in the brain
24. Erythropoietin gene expression in human, monkey and murine brain
25. A novel site of erythropoietin production: Oxygen-dependent production in cultured rat astrocytes
26. Do transient ischemic attacks have a neuroprotective effect?
27. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
28. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice
29. Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent
30. Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation-chemical preconditioning
31. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons
32. A fluorescence based non-radioactive electrophoretic mobility shift assay
33. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery
34. In vivo evidence that erythropoietin protects neurons from ischemic damage
35. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
36. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity
37. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
38. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats
39. Improved selective, simple, and contrast staining of acidophilic neurons with vanadium acid fuchsin
40. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
41. Attenuated stroke severity after prodromal TIA: Is it ischemic tolerance?
42. Respiratory chain inhibition induces tolerance to focal cerebral ischemia
43. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin